Serious Adverse Cutaneous Reactions to Drugs - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Serious Adverse Cutaneous Reactions to Drugs

Description:

Serious Adverse Cutaneous Reactions to Drugs – PowerPoint PPT presentation

Number of Views:500
Avg rating:3.0/5.0
Slides: 35
Provided by: michae325
Category:

less

Transcript and Presenter's Notes

Title: Serious Adverse Cutaneous Reactions to Drugs


1
Serious Adverse Cutaneous Reactions to Drugs
  • Michael Bigby, MD
  • Department of Dermatology
  • Harvard Medical School and
  • Beth Israel Deaconess Medical School
  • Boston, MA
  • mbigby_at_bidmc.harvard.edu

2
Identifying Drug Eruptions
  • Identify rash as a drug eruption
  • Exclude alternative causes
  • Examine exposure-rash interval
  • Note response to drug withdrawal
  • Check drugs history
  • Note response to re-exposure

3
Common Drug Rashes
  • Exanthem
  • Urticaria
  • Fixed-drug eruption

4
(No Transcript)
5
Identifying Culprit Drug
  • Timing
  • Rates of reactions
  • Response to withdrawal
  • Re-challenge

6
Timing
  • 1 to 3 days
  • Up to 2 weeks (antibiotics and allopurinol)

7
Determining Rates of Reactions
  • Prospectively collected data
  • Retrospective studies
  • Spontaneous reports/consumption

8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
Common Urticaria Producers
  • Same as exanthem producers
  • Histamine releasers

12
(No Transcript)
13
Common Fixed-drug Producers
  • Co-trimoxazole
  • Naproxen
  • Dipyrone
  • Oxicams
  • Tetracyclines
  • Phenolphthalein

14
Serious Drug Rashes
  • Toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • Drug hypersensitivity syndrome

15
(No Transcript)
16
Toxic Epidermal Necrolysis
  • Prodrome fever, malaise
  • Pupuric plaques, bullae, face torso
  • Mucosa involved
  • Wide areas of epidermal detachment gt30
  • Mortality 30 (infection, respiratory)

17
Epidemiology of TEN
  • Incidence 0.4 to 1.2 per million person-years
  • Drug-induced (95)
  • High incidence with some drugs (1 to 14 per
    100,000 users)

18
Epidemiology of TEN
  • Sulfonamides
  • Trimethoprim-sulfamethoxazole
  • Carbamazepine
  • Oxicams
  • Excess risk per million users/week
  • NEJM 19953331600

4.5 4.3 2.5 2.0
19
Toxic Epidermal Necrolysis
  • Hydantoins
  • Sulfonamides
  • NSAIDS
  • Allopurinol

20
Stevens-Johnson Syndrome
  • Prodrome fever, malaise
  • Pupuric plaques, bullae, face torso
  • Mucosa involved
  • Limited area of epidermal detachment lt10
  • Mortality lt5

21
Epidemiology of SJS
  • Incidence and 1.2 to 6 per million person-years
  • Drug-induced (50)
  • High incidence with some drugs

22
Drugs Implicated in TEN and SJS
  • Hydantoins
  • Sulfonamides
  • NSAIDS
  • Allopurinol

23
(No Transcript)
24
(No Transcript)
25
Drug Hypersensitivity Syndrome
  • Exanthem
  • Fever
  • Hepatitis
  • Lymphadenopathy

26
Drugs Implicated in Hypersensitivity
  • Hydantoins
  • Anti-epileptics
  • Sulfonamides

27
NEJM 19943311272
28
NEJM 19943311272
29
Mimics of Drug Rashes
  • Erythema Multiforme
  • Grovers disease
  • Pityriasis rosea
  • Viral exanthem
  • Graft vs host disease

30
(No Transcript)
31
(No Transcript)
32
(No Transcript)
33
Mimics of Drug Rashes
  • Grovers disease
  • Pityriasis rosea
  • Viral exanthem
  • Graft vs host disease

34
Serious Adverse Cutaneous Reactions to Drugs
  • Michael Bigby, MD
  • Department of Dermatology
  • Harvard Medical School and
  • Beth Israel Deaconess Medical School
  • Boston, MA
  • mbigby_at_bidmc.harvard.edu
Write a Comment
User Comments (0)
About PowerShow.com